65818-01-1 Usage
General Description
4H-Cyclopentapyrimidin-4-one, 3,5,6,7-tetrahydro-2-methyl- (9CI), also known by its chemical formula C8H12N2O, is a heterocyclic compound with a cyclopentapyrimidinone core structure. It is a derivative of cyclopentapyrimidinone and is characterized by its 3,5,6,7-tetrahydro-2-methyl substituents. 4H-Cyclopentapyrimidin-4-one, 3,5,6,7-tetrahydro-2-methyl- (9CI) has potential pharmaceutical significance due to its heterocyclic structure, which can be useful in developing new drugs targeting specific biological pathways. It is important for further research and evaluation for its potential pharmacological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 65818-01-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,8,1 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 65818-01:
(7*6)+(6*5)+(5*8)+(4*1)+(3*8)+(2*0)+(1*1)=141
141 % 10 = 1
So 65818-01-1 is a valid CAS Registry Number.
65818-01-1Relevant articles and documents
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer
Yang, Zhuang,Wang, Taijin,Wang, Fang,Niu, Ting,Liu, Zhuowei,Chen, Xiaoxin,Long, Chaofeng,Tang, Minghai,Cao, Dong,Wang, Xiaoyan,Xiang, Wei,Yi, Yuyao,Ma, Liang,You, Jingsong,Chen, Lijuan
, p. 1455 - 1470 (2016/03/08)
Novel selective histone deacetylase 6 (HDAC6) inhibitors using the quinazoline as the cap were designed, synthesized, and evaluated for HDAC enzymatic assays. N-Hydroxy-4-(2-methoxy-5-(methyl(2-methylquinazolin-4-yl)amino)phenoxy)butanamide, 23bb, was the
Saturated heterocyclics. 45. Synthesis of 2-substituted-5,6-trimethylene- and 5,6-tetramethylenepyrimidine-4(3H)-ones for pharmacologic testing
Bernath,Janaky,Goendoes,Lazar,Ecsery
, p. 270 - 271 (2007/10/02)
-
